Study Title: Oncological and Functional Results After Total Laryngectomy and Pharyngolaryngectomy

NCT07287865 — Active not recruiting, 400 participants, Fondazione IRCCS Policlinico San Matteo di Pavia

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07287865, acronym TL&TPL
StatusActive not recruiting
Study typeObservational
Enrollment400 (Estimated)
SponsorFondazione IRCCS Policlinico San Matteo di Pavia (Other)
ConditionsLaryngeal and Hypopharyngeal Tumors
Interventionssurgical flap (Procedure)
Datesstart 2025-03-14, primary completion 2030-12-01 (estimated), completion 2030-12-31 (estimated), first posted 2025-12-17, last updated 2025-12-17
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for Laryngeal and Hypopharyngeal Tumors All trials of surgical flap

-Summary

Salvage total laryngectomy (TL) and total pharyngolaryngectomy (TPL) are the gold standard for most recurrent laryngeal and hypopharyngeal tumors as well as in patients with contraindication for chemoradiotherapy (CRT). Free or pedicled flaps are the two mandatory options for pharyngeal reconstruction after TPL, while remain an optional indication to protect the neopharynx after TL. The most common complication after TL or TPL is pharyngocutaneous fistula (PCF), with an incidence ranging from 3% to 65%, according to the surgical defect and type of reconstruction. The etiology of PCF is multifactorial and the most important risk factors are a history of CRT, low hemoglobin levels (< 12.5 g/dl), and malnutrition. A growing concern is the role of nutritional status, with sarcopenia as an emergent risk factor for post-operative complications, because muscle wasting negatively influences wound healing and overall recovery. Salivary stent placement, 3-layers neopharyngeal sutures, cricopharyngeal myotomy and prophylactic use of vascularized flaps are possible protective factors to reduce the risk of PCF. Despite these evidences, it remains unclear which are the best candidates for flap reconstruction, as well as which preoperative risk factors influence the risk of PCF.

The rationale of this ambispective monocentric study is to identify the risk factors statistically significant associated with the development of PCF and the influence of preoperative sarcopenia on postoperative complications risks following TL and TPL.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
reconstructive flapProcedure: surgical flappatients affected by laryngeal and/or hypopharyngeal carcinoma who underwent/undergo total laryngectomy, total hemipharyngolaryngectomy, or circular pharyngolaryngectomy, with reconstructive flap, from January 2015 to December 2030
NO reconstructive flappatients affected by laryngeal and/or hypopharyngeal carcinoma who underwent/undergo total laryngectomy, total hemipharyngolaryngectomy, or circular pharyngolaryngectomy,without reconstructive flap, from January 2015 to December 2030
  • surgical flap (Procedure): Pedicled or free flap was harvested and placed over the pharyngeal suture (on-lay) following TL or tunnelled to reconstruct wide defects (in-lay) after TPL.

+Outcome measures

Primary outcomes

  • The association between the use of a surgical flap and the incidence of post-operative fistulas during follow-up [within 30 days from surgery]: Proportion of subjects who develop a post-operative fistula (blind or pharyngo-cutaneous fistula, PCF, with or without the use of a surgical flap, which develop within 30 days from surgery

Secondary outcomes

  • The association between the use of a surgical flap and the incidence of mid to longterm post-operative fistulas [30 days and at mid to long term.]: The rate of development of a mid to longterm post-operative fistula
  • Potential correlates of fistulas development both within 30 days and at mid to long term [30 days and 36 months]: * Demographic and medical history * Tumor characteristics * Previous tumor treatment * Laboratory * Perioperative management
  • The incidence of any post-operative complications [1-36 months follow-up]: Fistulas and any of the surgical and non surgical complications within 30 days. Surgical complications (require reintervention): * Necroses * Hematoma/hemorrage * Neopharyngeal stenosis Non surgical Complications: * Hypocalcemia * Anemia requiring blood transfusion * Hypokalemia * Pneumonia * Cardiac complications * Infection
  • 36 months incidence of tumor related events [36 months after surgery]: Potential correlates will be: * The combination of surgical flap and fistula * The lymphnode ratio </≥18 (LNR, calculated as the number of positive lymph nodes divided by the total number of lymph nodes removed, including both positive and negative nodes ) * Sarcopenia
  • The prognostic role of both the use of a surgical flap and the development of post-operative fistulas [36 months after surgery]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

Patients undergoing to TL with direct closure of the pharynx or TPL and reconstruction of the pharynx with a free or pedicled flap in cases of:

* Naive laryngeal neoplasia (cT1-cT4a with possible extension to the esophagus, oropharynx, or hypopharynx);
* Recurrence of laryngeal or hypopharyngeal cancer in patients previously treated with surgical intervention (TLM/CO2 laser or OPHL);
* Recurrence of laryngeal or hypopharyngeal cancer in patients previously treated with RT or CRT;
* Loss of laryngeal function induced by RT, CRT, or OPHL treatment;
* Availability of data according to the assessments that must be made, including a follow-up period of at least 2 months.

Exclusion Criteria:

* Lack of useful data to carry out the assessments related to the study itself

+Locations (1)

FacilityCityCountryStatus
SC Otorinolaringoiatria - Fondazione IRCCS Policlinico San Matteo, PaviaPavia, PaviaItaly

+Investigators

  • Marco Benazzo, MD, Principal investigator, Fondazione IRCCS Policlinico San Matteo di Pavia